Publications
39
Citations
1,212
Est. group size
~2
Recurring co-author estimate
Active years
16
Publishing since 2010
Matthew E. Long's research focuses on how immune cells, particularly macrophages, drive inflammation in chronic lung diseases such as cystic fibrosis, COPD, and bacterial lung infections. A recurring theme is targeting cell-signaling pathways (like MEK1/2) and testing drugs (such as CFTR modulators and gallium compounds) to reduce harmful inflammation while preserving the body's ability to fight infection. Work also extends to broader topics including gene editing safety and genetic risk factors in other diseases.
Publication output has been relatively steady with some fluctuation, averaging about 3 papers per year over the last five years, with recent upticks in 2024 and 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Common SNCA Genetic Variants and Parkinson’s Disease Risk: A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 2025
- 419 The MEK1/2 inhibitor ATR-002 has dual anti-inflammatory and antibacterial effects during <i>S. aureus</i> infection
Journal of Clinical and Translational Science · 2025
- Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
Med · 2022
- Modifying Macrophage Phenotypes to Dampen Airway Inflammation in Chronic Lung Diseases
2022
- 514 Anti-inflammatory effects of MEK1/2 inhibitors on cystic fibrosis macrophages
Journal of Cystic Fibrosis · 2022
- 596 Evaluating preexisting immunity to CRISPR/Cas9 gene editing technologies
Journal of Cystic Fibrosis · 2022
- 370: Modifying macrophage phenotypes to dampen nonresolving CF airway inflammation: Gallium nitrate as the next azithromycin?
Journal of Cystic Fibrosis · 2021
- Targeting Eukaryotic Kinase Pathways as an Anti-Inflammatory Approach for Cystic Fibrosis
2021
- CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis
Frontiers in Pharmacology · 2020
- Evaluation of Nutritional Gel Supplementation in C57BL/6J Mice Infected with Mouse-Adapted Influenza A/PR/8/34 Virus
Comparative Medicine · 2020
- Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis
ERJ Open Research · 2020
- Loss of C/EBPα in Chronic Cigarette Smoke Exposure: A SAD Day for Chronic Obstructive Pulmonary Disease
American Journal of Respiratory Cell and Molecular Biology · 2020
- Gallium as a Potential Novel Anti-Inflammatory Therapy in Bacterial Lung Disease
2020
- MEK1 regulates pulmonary macrophage inflammatory responses and resolution of acute lung injury
JCI Insight · 2019
- Transcriptional and functional diversity of human macrophage repolarization
Journal of Allergy and Clinical Immunology · 2018
- Journal of Cystic Fibrosis×3
- Molecular Therapy×2
- JCI Insight×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
- Clinical Science×1
- Estelle Cormet‐Boyaka
Medicine · The Ohio State University
- Karen McCoy
Medicine · The Ohio State University
- James F. Chmiel
Medicine · Indiana University
- Charles Clem
Medicine · Indiana University
- Michelle S. Howenstine
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile